GESSEL advises Lux Med on acquisition of TMS Diagnostyka
21.04.2026 Case studies Mergers and acquisitions (M&A) Typical scope of services provided in an M&A transaction on the buy side Life Sciences and Health Care
GESSEL advised Lux Med sp. z o.o., a leading private healthcare provider in Poland, on the acquisition of 100% of the shares in TMS Diagnostyka sp. z o.o., a Poland based medical imaging provider operating a diagnostic centre in Białystok. Lux Med is part of British United Provident Association Ltd, an international healthcare and insurance group.
The transaction supports Lux Med’s strategy to expand its medical imaging platform and strengthen its presence in regional markets. GESSEL advised on all aspects of the transaction, including legal due diligence, structuring and transaction documentation.
“This transaction reflects our experience in advising on healthcare transactions and our ability to address sector specific regulatory and operational considerations. We are pleased to have supported Lux Med on this project,” said Bartłomiej Woźniak, Managing Associate at GESSEL.
Lawyers involved in the project
Marcin Macieszczak
Managing partner
Attorney-at-law
Mergers and acquisitions (M&A) | Private Equity
Bartłomiej Woźniak PhD
Managing Associate
Advocate
Mergers and acquisitions (M&A) | Private Equity | Corporate law
Erazm Dutkiewicz
Senior Associate
Attorney-at-law
Corporate law | Life Sciences and Health Care
You may also like
20.05.2026
GESSEL advised CenterMed on the acquisition of NZOZ Partner
GESSEL advised CenterMed, a Polish medical group developing a network of healthcare facilities, on the acquisition of NZOZ Partner sp. z o.o., a healthcare services prov...
18.05.2026
GESSEL advised Bank Gospodarstwa Krajowego on the financing of the management buyout of the Jutrzenka group
GESSEL advised Bank Gospodarstwa Krajowego in connection with the provision of multi-million debt financing for the leveraged management buyout of shares in the Jutrzenk...